Conditions: Diabetes Mellitus, Type 2
Keywords: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 87
Healthy volunteers: no

Brief summary:
This drug is being evaluated for possible treatment of type 2 diabetes mellitus. Participation in this study is expected to last up to 18 weeks. A goal of this study is to determine the safety and effectiveness of LY2409021.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: LY2409021 intervention 2: Placebo
Intervention descriptions: intervention 1: 4 capsules by mouth taken once daily for 12 weeks intervention 2: 4 capsules by mouth once daily for 12 weeks

Protocol document: